Taiko Pharmaceutical News

Taiko Pharmaceutical: Consolidated financial results report for the 3rd quarter of the fiscal year ending 2024/12 (FY2024)

Nov 8, 2024 14:30

Taiko Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)

Nov 8, 2024 14:30

Taiko Pharmaceutical: Consolidated financial statements for the second quarter (interim period) of the fiscal year ending December 2024 (FY2024).

Aug 15, 2024 11:00

Taiko Pharmaceutical: Confirmatory letter.

Aug 9, 2024 14:34

Taiko Pharmaceutical: Interim Report - 79th period (January 1, 2024 - December 31, 2024)

Aug 9, 2024 14:33

Taiko Pharmaceutical: Announcements of individual stocks regarding the revision of consolidated performance estimates and the restructuring of production system in pharmaceutical business (recognition of impairment losses).

Aug 9, 2024 14:30

Taiko Pharmaceutical: 2024 December Q2 (Interim) Financial Results (Japan Standard) (Consolidated)

Aug 9, 2024 14:30

Taiko Pharmaceutical: Confirmation letter

May 10, 2024 14:37

Taiko Pharmaceutical: Quarterly Report - 79th Quarter 1 (2024/01/01 to 2024/03/31)

May 10, 2024 14:35

Taiko Pharmaceutical: Consolidated financial results report for the 1st quarter of the fiscal year ending 2024/12 (FY2024)

May 10, 2024 14:30

Taiko Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)

May 10, 2024 14:30

Taiko Pharmaceutical: Extraordinary Report

Apr 1, 2024 14:14

Taiko Pharmaceutical: Confirmation

Mar 28, 2024 14:28

Taiko Pharmaceutical: Financial Report - 78th Term (2023/01/01 - 2023/12/31)

Mar 28, 2024 14:26

Taiko Pharmaceutical: Notice Concerning the Recording of Special Profit and Revision of Consolidated Earnings Forecasts

Mar 7, 2024 14:30

Taiko Pharmaceutical: Consolidated financial results report for the fiscal year ending 2023/12 (FY2023)

Feb 15, 2024 11:00

Taiko Pharmaceutical: Extraordinary Report

Feb 9, 2024 14:36

Taiko Pharmaceutical: Notice regarding the recording of extraordinary loss (impairment loss) and the difference between consolidated earnings forecasts and actual values

Feb 9, 2024 14:30

Taiko Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending 2023/12 [Japanese GAAP] (Consolidated)

Feb 9, 2024 14:30

Taiko Pharmaceutical: Confirmation letter

Nov 10, 2023 14:38